MedTrace Logo

TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

NCT04450992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-07-31

No results posted yet for this study

Summary

TRACK-MSA is an observational, non-interventional, longitudinal natural history study to define changes in clinical, neurological, blood, CSF, and neuroimaging biomarkers in patients with multiple system atrophy (MSA) comparing baseline to 6-month and 1-year assessments. The study will enroll 50 patients with MSA-P or MSA-C at 2 or more participating sites.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jose-Alberto Palma, MD PhD · NYU School of Medicine

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-17
Primary Completion
2024-06-19
Completion
2024-06-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04450992 on ClinicalTrials.gov